Patient positioning variations to reduce dose to normal tissues during 3D conformal radiotherapy for high-risk prostate cancer

Strahlentherapie und Onkologie

Volumn 188, Issue 9, 2012, Pages 816-822

  Czigner, K ^a   Agoston P ^a   Forgacs G ^a   Kasler M ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

High risk prostate cancer; Normal tissue sparing; Patient positioning; Three dimensional conformal radiotherapy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BODY POSTURE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KNEE; MALE; PATIENT POSITIONING; PROSPECTIVE STUDY; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; SUPINE POSITION; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT POSITIONING; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIATION PROTECTION; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 84866657324     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0126-z     Document Type: Article

References (31)

1. Bayley AJ, Catton CN, Haycocks T et al (2004) A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother Oncol 70:37-44
2. Bittner N, Butler WM, Reed JL et al (2010) Electromagnetic tracking of intrafraction prostate displacement in patients externally immobilized in the prone position. Int J Radiat Oncol Biol Phys 77:490-495
3. Czigner K, Ágoston P, Forgács GY et al (2009) Assessment of overlapping of organs at risk and planning target volumes at high risk prostate cancer irradiation. Radiother Oncol 92(Suppl 1):69
4. Dawson LA, Litzenberg DW, Brock KK et al (2000) A comparison of ventilatory prostate movement in four treatment positions. Int J Radiat Oncol Biol Phys 48:319-323
5. De Meerleer GO, Villeirs GM, Vakaet L et al (2004) The incidence of inclusion of the sigmoid colon and small bowel in the planning target volume in radiotherapy for prostate cancer. Strahlenther Onkol 180:573-581
6. Dolezel M, Odrazka K, Vaculikova M et al (2010) Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy. Strahlenther Onkol 186:197-202
7. Gallagher MJ, Brereton HD, Rostock RA et al (1986) A prospective study of treatment techniques to minimise the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys 12:1565-1573
8. Hanks GE, Hanlon AL, Epstein B et al (2002) Dose response in prostate cancer with 8-12 years follow-up. Int J Radiat Oncol Biol Phys 54:427-435
9. Hentschel B, Oehler W, Strauss D et al (2011) Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer. Strahlenther Onkol 187:183-190
10. Hille A, Töws N, Schmidberger H, Hess CF (2005) A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio. Strahlenther Onkol 181:789-795
11. Huang EH, Pollack A, Levy L et al (2002) Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54:1314-1321
12. Kato T, Obata Y, Kadoya N et al (2009) A comparison of prone three-dimensional conformal radiotherapy with supine intensity-modulated radiotherapy for prostate cancer: which technique is more effective for rectal sparing? Br J Radiol 82:654-661
13. Kitamura K, Shirato H, Seppenwoolde Y et al (2002) Three-dimensional intrafractional movement of prostate measured during real-time tumortracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys 53:1117-1123
14. Kuban DA, Tucker SL, Dong L et al (2008) Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70:67-74
15. Liu B, Lerma FA, Patel S et al (2008) Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy. Radiother Oncol 88:67-76
16. McLaughlin PW, Evans C, Feng M et al (2010) Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy. Int J Radiat Oncol Biol Phys 76:369-378
17. McLaughlin PW, Wygoda A, Sahijdak W et al (1999) The effect of patient position and treatment technique in conformal treatment of prostate cancer. Int J Radiat Oncol Biol Phys 45:407-413
18. Michalski JM, Bae K, Roach M et al (2010) Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study. Int J Radiat Oncol Biol Phys 76:14-22
19. Michalski JM, Purdy JA, Winter K et al (2000) Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 46:391-402
20. Nakamura N, Shikama N, Takahashi O et al (2010) Variability in bladder volumes of full bladders in definitive radiotherapy for cases of localized prostate cancer. Strahlenther Onkol 186:637-642
21. Onal C, Topkan E, Efe E et al (2009) Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis. Radiat Oncol 11(4):14
22. O'Neill L, Armstrong J, Buckney S et al (2008) A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer. Radiother Oncol 88:61-66
23. Pinkawa M, Piroth MD, Holy R et al (2011) Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlenther Onkol 187:479-484
24. Shah AP, Kupelian PA, Willoughby TR et al (2011) An evaluation of intrafraction motion of the prostate in the prone and supine positions using electromagnetic tracking. Radiother Oncol 99:37-43
25. Storey MR, Pollack A, Zagars G (2000) Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48:635-642
26. Szumacher E, Harnett N, Warner S et al (2010) Effectiveness of educational intervention on the congruence of prostate and rectal contouring as compared with a gold standard in three-dimensional radiotherapy for prostate. Int J Radiat Oncol Biol Phys 76:379-385
27. Viani GA, Stefano EJ, Afonso SL (2009) Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys 74:1405-1418
28. Wilder RB, Chittenden L, Mesa AV et al (2009) A prospective study of intrafraction prostate motion in the prone vs. supine position. Int J Radiat Oncol Biol Phys 77:165-170
29. Zelefsky MJ, Happersett L, Leibel SA et al (1997) The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 37:13-19
30. Zelefsky MJ, Leibel SA, Gaudin PB et al (1998) Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41:491-500
31. Zelefsky MJ, Levin EJ, Hunt M et al (2008) Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70:1124-1129